Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proinflammatory cytokine secretion, specifically the TNF-α-induced production and secretion of IL-8, is a key inflammatory pathway. TNF-α stimulates cells, leading to NF-kB and PI3K/Akt activation, resulting in increased IL-8 expression. IL-8, a chemokine, recruits neutrophils and other immune cells, amplifying inflammation. This process is implicated in various diseases, including autoimmune disorders and cytokine storms. Therapeutic strategies target TNF-α or downstream signaling molecules to reduce IL-8 production and its inflammatory effects.
Inhibition of TNF-α signaling to reduce IL-8 production; blockade of IL-8 receptor (CXCR1/CXCR2) to prevent neutrophil recruitment
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proinflammatory Cytokine Secretion (TNF-alpha-induced IL-8) (TNFα-induced IL-8 Secretion).